1
|
Zheng S, Zhang Z, Ma J, Qu Q, God'spowe B, Qin Y, Chen X, Li LU, Zhou D, Ding W, Li Y. CD-g-CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection. Microb Biotechnol 2022; 15:535-547. [PMID: 34180582 PMCID: PMC8867972 DOI: 10.1111/1751-7915.13870] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 06/02/2021] [Accepted: 06/06/2021] [Indexed: 11/30/2022] Open
Abstract
Staphylococcus xylosus (S. xylosus)-induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur-loaded chitosan grafted with β-cyclodextrins (CD-g-CS) nanoparticles (CT-NPs) using host-guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT-NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus-induced mastitis, CT-NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections.
Collapse
Affiliation(s)
- Si‐Di Zheng
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Zhi‐Yun Zhang
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Jin‐Xin Ma
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Qian‐Wei Qu
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Bello‐Onaghise God'spowe
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Yue Qin
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - Xue‐Ying Chen
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| | - LU Li
- College of Life ScienceNortheast Agricultural UniversityHarbin, Heilongjiang150030China
| | - Dong‐Fang Zhou
- School of Pharmaceutical SciencesSouthern Medical UniversityGuangzhou510515China
| | - Wen‐Ya Ding
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
- School of PharmacyGuangxi University of Chinese MedicineNanning530200China
| | - Yan‐Hua Li
- College of Veterinary MedicineNortheast Agricultural UniversityHarbin, Heilongjiang150030China
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical DevelopmentHarbin, Heilongjiang150030China
| |
Collapse
|
2
|
Zhou YH, Xu CG, Yang YB, Xing XX, Liu X, Qu QW, Ding WY, Bello-Onaghise G, Li YH. Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus. Front Microbiol 2018; 9:665. [PMID: 29675012 PMCID: PMC5896262 DOI: 10.3389/fmicb.2018.00665] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2017] [Accepted: 03/21/2018] [Indexed: 12/20/2022] Open
Abstract
Staphylococcus xylosus (S. xylosus) is an AT-rich and coagulase-negative Staphylococcus (CNS). It is normally regarded as non-pathogenic, however, recent studies have demonstrated that it is related to human opportunistic infections and bovine mastitis. In addition, S. xylosus strains have the ability to form biofilm. Biofilms are also involved in chronic infections and antibiotic resistance, there are only a few reports about cefquinome inhibiting S. xylosus biofilm formation and the protein targets of cefquinome. In our study, we found that sub-MICs of cefquinome were sufficient to inhibit biofilm formation. To investigate the potential protein targets of cefquinome, we used iTRAQ for the analyses of cells at two different conditions: 1/2-MIC (0.125 μg/mL) cefquinome treatment and no treatment. Using iTRAQ technique and KEGG database analysis, we found that proteins differently expression in histidine metabolism pathway may play a role in the process by which 1/2-MIC (0.125 μg/mL) cefquinome inhibits S. xylosus biofilm formation. Interestingly, we found a sharply down-regulated enzyme [A0A068E9J3 imidazoleglycerol-phosphate dehydratase (IGPD)] involved in histidine metabolism pathway in cefquinome-treated cells. We demonstrated the important role of IGPD in sub-MICs cefquinome inhibiting biofilm formation of S. xylosus by gene (hisB) knockout, IGPD enzyme activity and histidine content assays. Thus, our data sheds light on important role of histidine metabolism in S. xylosus biofilm formation; especially, IGPD involved in histidine metabolism might play a crucial role in sub-MICs cefquinome inhibition of biofilm formation of S. xylosus, and we propose IGPD as an attractive protein target of cefquinome.
Collapse
Affiliation(s)
- Yong-Hui Zhou
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Chang-Geng Xu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Yan-Bei Yang
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Xiao-Xu Xing
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Xin Liu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Qian-Wei Qu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Wen-Ya Ding
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - God'spower Bello-Onaghise
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| | - Yan-Hua Li
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.,Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China
| |
Collapse
|
3
|
Insight into the Genome of Staphylococcus xylosus, a Ubiquitous Species Well Adapted to Meat Products. Microorganisms 2017; 5:microorganisms5030052. [PMID: 28850086 PMCID: PMC5620643 DOI: 10.3390/microorganisms5030052] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Revised: 08/21/2017] [Accepted: 08/25/2017] [Indexed: 01/23/2023] Open
Abstract
Staphylococcus xylosus belongs to the vast group of coagulase-negative staphylococci. It is frequently isolated from meat products, either fermented or salted and dried, and is commonly used as starter cultures in sausage manufacturing. Analysis of the S. xylosus genome together with expression in situ in a meat model revealed that this bacterium is well adapted to meat substrates, being able to use diverse substrates as sources of carbon and energy and different sources of nitrogen. It is well-equipped with genes involved in osmotic, oxidative/nitrosative, and acidic stress responses. It is responsible for the development of the typical colour of cured meat products via its nitrate reductase activity. It contributes to sensorial properties, mainly by the the catabolism of pyruvate and amino acids resulting in odorous compounds and by the limiting of the oxidation of fatty acids, thereby avoiding rancidity.
Collapse
|